|
KLHL9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81288317691042E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04450012475377E-10 |
| Normal-vs-Stage2 |
1.15850000004247E-06 |
| Normal-vs-Stage3 |
1.24877885809838E-12 |
| Normal-vs-Stage4 |
2.49833487231399E-12 |
| Stage1-vs-Stage2 |
5.101000E-01 |
| Stage1-vs-Stage3 |
2.336400E-02 |
| Stage1-vs-Stage4 |
5.809200E-04 |
| Stage2-vs-Stage3 |
3.854600E-01 |
| Stage2-vs-Stage4 |
8.499700E-02 |
| Stage3-vs-Stage4 |
2.032000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.44799793956008E-14 |
| Normal-vs-AfricanAmerican |
1.142520E-03 |
| Normal-vs-Asian |
8.18119999967948E-07 |
| Caucasian-vs-AfricanAmerican |
2.103400E-01 |
| Caucasian-vs-Asian |
4.663200E-01 |
| AfricanAmerican-vs-Asian |
5.517200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84263715397037E-12 |
| Normal-vs-Female |
8.33477731276844E-12 |
| Male-vs-Female |
1.859240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.61790000285933E-08 |
| Normal-vs-Age(41-60Yrs) |
6.78013201138583E-13 |
| Normal-vs-Age(61-80Yrs) |
7.13740178071021E-12 |
| Normal-vs-Age(81-100Yrs) |
2.258100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.339800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.807850E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.596000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.374000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.346400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.861200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.979200E-03 |
| Classical-VS-Follicular |
8.072500E-02 |
| Classical-VS-Other |
2.148000E-01 |
| Classical-VS-Normal |
1.82200032838864E-10 |
| Tall-VS-Follicular |
2.424600E-01 |
| Tall-VS-Other |
9.196800E-01 |
| Tall-VS-Normal |
1.4775003442935E-10 |
| Follicular-VS-Other |
5.683800E-01 |
| Follicular-VS-Normal |
2.25910001816487E-09 |
| Other-VS-Normal |
9.966700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.95380395090683E-11 |
| Normal-vs-N1 |
7.04789560046493E-11 |
| N0-vs-N1 |
1.085390E-01 |
|
|
